{"id":"W3208513157","doi":"10.1016/j.jtocrr.2021.100251","title":"Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Takeda Canada; Bristol-Myers Squibb Canada; EMD Serono; Amgen; Boehringer Ingelheim; Meso Scale Diagnostics; Sanofi; Roche; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Internal medicine; Hazard ratio; Stage (stratigraphy); Adverse effect; Incidence (geometry); Chemotherapy; Oncology; Cancer; Confidence interval; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003641651,0.00008315493,0.0002641568,0.0001066777,0.000089837,0.0002036162,0.0001011781,0.00009645423,0.0004181831],"category_scores_gemma":[0.0007224383,0.00003881882,0.0002104434,0.0001673799,0.0001069786,0.0001618404,0.00009733012,0.0001719099,0.00006869039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003172377,"about_ca_system_score_gemma":0.0002576883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006338758,"about_ca_topic_score_gemma":0.002158284,"domain_scores_codex":[0.9999099,0.00002395918,0.00001232128,0.00001797183,0.00002516957,0.00001080156],"domain_scores_gemma":[0.9996364,0.00008503778,0.0001705977,0.00002256386,0.00002758167,0.00005779941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02434155,0.0006465393,0.6618378,0.0003740951,0.0007286401,0.0003818491,0.000134212,0.0005508436,0.01547066,0.00009705615,0.0008175139,0.2946191],"study_design_scores_gemma":[0.001367897,0.01565501,0.9687566,0.0001182701,0.0007400665,0.002133309,0.00009314209,0.001192798,0.005849831,0.0001114751,0.003969907,0.00001161933],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994142,0.005065672,0.0001077656,0.0000529239,0.000008152245,0.00001271732,0.00008355179,0.000004902151,0.0005222789],"genre_scores_gemma":[0.9984676,0.001090969,0.0001451726,0.00004622045,0.00001682102,0.000006349312,0.0001226525,0.000001302276,0.0001029754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006338758,"threshold_uncertainty_score":0.002301693,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0722457016137158,"score_gpt":0.4211569068315087,"score_spread":0.348911205217793,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}